#pathos ai Tech News.
1 story in the last 7 days
The latest pathos ai news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks pathos ai across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AIFinancial Timesabout 2 hours ago
Pathos AI Licenses JSKN016 from Alphamab OncologyPathos AI entered a global licensing agreement with Alphamab Oncology for JSKN016, a first-in-class TROP2/HER3 bispecific ADC. The deal grants Pathos AI worldwide rights to develop and commercialize the candidate. Financial terms were not disclosed.
Summaries by ByteBrief